Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Incyte Corp (NASDAQ: INCY) closed at $55.17 down -6.27% from its previous closing price of $58.86. In other words, the price has decreased by -$6.27 from its previous closing price. On the day, 2.68 million shares were traded. INCY stock price reached its highest trading level at $58.33 during the session, while it also had its lowest trading level at $53.865.
Ratios:
For a deeper understanding of Incyte Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 42.87. For the most recent quarter (mrq), Quick Ratio is recorded 1.94 and its Current Ratio is at 1.97. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On December 17, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $77.UBS initiated its Neutral rating on December 17, 2024, with a $77 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 14 ’25 when Flannelly Barry P sold 19,807 shares for $67.69 per share. The transaction valued at 1,340,656 led to the insider holds 33,567 shares of the business.
BARRY FLANNELLY bought 19,807 shares of INCY for $1,340,728 on Mar 14 ’25. On Mar 04 ’25, another insider, Denton Sheila A., who serves as the EVP & General Counsel of the company, sold 599 shares for $69.99 each. As a result, the insider received 41,924 and left with 25,848 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INCY now has a Market Capitalization of 10676718592 and an Enterprise Value of 9625950208. As of this moment, Incyte’s Price-to-Earnings (P/E) ratio for their current fiscal year is 203.43, and their Forward P/E ratio for the next fiscal year is 8.54. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.52 while its Price-to-Book (P/B) ratio in mrq is 3.10. Its current Enterprise Value per Revenue stands at 2.27 whereas that against EBITDA is 54.201.
Stock Price History:
The Beta on a monthly basis for INCY is 0.69, which has changed by 0.02451253 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, INCY has reached a high of $83.95, while it has fallen to a 52-week low of $50.35. The 50-Day Moving Average of the stock is -17.95%, while the 200-Day Moving Average is calculated to be -18.57%.
Shares Statistics:
For the past three months, INCY has traded an average of 1.92M shares per day and 2508390 over the past ten days. A total of 193.43M shares are outstanding, with a floating share count of 190.50M. Insiders hold about 1.56% of the company’s shares, while institutions hold 95.69% stake in the company. Shares short for INCY as of 1741910400 were 6359808 with a Short Ratio of 3.74, compared to 1739491200 on 8323615. Therefore, it implies a Short% of Shares Outstanding of 6359808 and a Short% of Float of 5.82.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
